| Female | 32 (36) |
| Age yrs | 35 (27–47) |
| Weight kg | 58.3 (49.6–66.7) |
| Length cm | 170 (162–175) |
| BMI kg·m−2 | 20.1 (17.9–23.0) |
| Ethnicity | |
| Caucasian | 29 (32.6) |
| Asian | 17 (19.1) |
| African | 41 (46.1) |
| Other | 2 (2.3) |
| Duration of hospital stay days | 62.5 (35–112.3) |
| Tuberculosis | |
| Localisation | |
| Pulmonary | 67 (75.3) |
| Extrapulmonary | 29 (32.6) |
| Other | 5 (5.6) |
| Diagnosis | |
| Sputum | 60 (67.4) |
| Other¶,+ | 29 (32.6) |
| Resistance pattern | |
| Fully susceptible | 54 (60.7) |
| MDR | 20 (22.5) |
| INH resistant | 2 (2.3) |
| INH and ethambutol resistant | 1 (1.1) |
| Unknown | 12 (13.5) |
| Comorbidity | |
| Chronic pre-existent liver disease | 5 (5.6) |
| Chronic renal dysfunction | 1 (1.1) |
| Epilepsy | 1 (1.1) |
| Diabetes mellitus | 10 (11.2) |
| HIV co-infection | 10 (11.2) |
| Alcohol abuse | 8 (9.0) |
Data are presented as n (%) or median (interquartile range). #: n=89. BMI: body mass index; MDR: multidrug resistant; INH: isoniazid. ¶: diagnosis based on clinical conditions, chest radiograph, histology and/or response to therapy. +: in 29 cases, diagnosis is based on clinical conditions, chest radiograph, histology and/or response to therapy; in 17 out of 29 patients the resistance pattern was determined at a later stage.